Scholars Central

Conference abstract

A biochemical and histo-morphometric study of the potential anabolic and antiresorptive effects of Methionine amino acid on ovariectomy induced osteoporosis

Authors: Nagwa Mahmoud Nour Eldin, Mohamed Mustafa Khedr, Hoda Mahmoud Khalifa, Sahar Ahmed Harby, Rasha Mohamed Adel Nassra

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Osteoporosis is a growing public health problem in both developed and developing countries, particularly among postmenopausal women. The seriousness of the disease comes from the increased risk of fracture, increasing with age. Most of established osteoporosis pharmacological treatments are associated with risky side effects, for example ulcer and renal toxicity with bisphosphonates, and cardiovascular complications with hormone replacement therapy. Therefore, development of safer prophylactic and treatment strategies is needed. This study aims at assessing the effect of methionine on ovariectomized rat model of postmenopausal osteoporosis. Female albino rats were divided into four groups: (I) sham rats (normal control), (II) ovariectomized (osteoporosis control), (III) ovariectomized + alendronate 0.1 mg/kg orally daily for 8 weeks, (IV) ovariectomized + methionine 250 mg/kg orally daily for 8 weeks. Serum osteocalcin and tartrate-resistant acid phosphatase 5b (TRAP5b) were determined. Histomorphometric measurement of trabecular and cortical bone thickness was done and analyzed. Treatment of ovariectomized rats with methionine produced both anabolic and antiresorptive effects on bone. The anabolic effect wasevidenced by histological signs of bone formation and histomorphometric analysis revealing increased bone thickness compared to group II and III. The significantly lower serum TRAP5b compared to group II and histomorphometric analysis evidenced the antiresorptive effect. The results of our study suggested potential anabolic and antiresorptive effects of methionine in postmenopausal osteopororsis. However, further studies on the efficacy as well as safety of methionine treatment inpostmenopausal osteopororsis in human and comparing it with the only approved, until now, bone anabolic drug, teriparatide, is recommended.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Clinical & Experimental Pharmacology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical & Experimental Pharmacology
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Nagwa Mahmoud Nour Eldin”
  • BylineArticles whose byline prints “Mohamed Mustafa Khedr”
  • BylineArticles whose byline prints “Hoda Mahmoud Khalifa”
  • BylineArticles whose byline prints “Sahar Ahmed Harby”
  • BylineArticles whose byline prints “Rasha Mohamed Adel Nassra”